Landrew
Bluelighter
(Bloomberg) -- The fast rise of prescriptions for Adderall and other stimulants, along with rampant online treatment and advertising, suggest the start of another drug crisis like the opioid epidemic, a senior Drug Enforcement Administration official said Thursday.
The warning is the most urgent public message yet on these types of drugs by the agency.
“I’m not trying to be a doomsday-er here,” said Matthew Strait, deputy assistant administrator in the diversion control division said in an online seminar. But he compared the current situation with stimulants to the beginning of the opioid crisis and said “it makes me feel like we’re at the precipice of our next drug crisis in the United States.”
The DEA’s position on stimulants will have a direct effect on how many are manufactured, pharmacies’ access to them and how patients get prescriptions.
Read More: Transcript: How The American Workforce Got Hooked on Adderall
www.bnnbloomberg.ca
The warning is the most urgent public message yet on these types of drugs by the agency.
“I’m not trying to be a doomsday-er here,” said Matthew Strait, deputy assistant administrator in the diversion control division said in an online seminar. But he compared the current situation with stimulants to the beginning of the opioid crisis and said “it makes me feel like we’re at the precipice of our next drug crisis in the United States.”
The DEA’s position on stimulants will have a direct effect on how many are manufactured, pharmacies’ access to them and how patients get prescriptions.
Read More: Transcript: How The American Workforce Got Hooked on Adderall

Adderall Abuse Risks Becoming Another Opioid Crisis, DEA Says - BNN Bloomberg
The fast rise of prescriptions for Adderall and other stimulants, along with rampant online treatment and advertising, suggest the start of another drug crisis like the opioid epidemic, a senior Drug Enforcement Administration official said Thursday.